期刊文献+

不同分期系统对晚期肝癌预后预测价值的分析 被引量:9

Clinical prognostic classification assessment for advanced hepatocellular carcinoma
原文传递
导出
摘要 目的:评价不同分期系统对晚期肝癌预后的预测价值,为晚期肝癌临床预后分组标准的建立提供一定的理论依据。方法:使用1989年Child-Pugh评分、2002年TNM分期和进展期肝癌预后系统(ALCPS)在诊断时对169例进展期肝癌患者进行评分,并随访。通过Kaplan-Meier、接受者工作特征曲线(ROC)及Logistic等方法评价不同评分系统对3个月生存率及总生存的预测价值。结果:Kaplan-Meier曲线提示ALCPS各曲线无效,有良好区分价值。Logistic回归及ROC曲线发现,ALCPS对于不经任何抗肿瘤治疗的晚期肝癌患者3个月生存率的预测价值最大,曲线下面积高达0.85,以14分左右预测切点,具有81.82%(72/88)的敏感性及79.01%(64/81)的特异性,P=0.000 1。结论:ALCPS是预测晚期肝癌3个月生存率的良好评分系统,可为晚期肝癌临床预后分组提供参考。 OBJECTIVE: To evaluate current prognostic score systems in predicting prognosis of patients with advanced hepatocellular carcinoma (HCC) ,and stratify the prognosis of these patients. METHODS: A total of 169 advanced HCC patients were included. Data were collected to classify patients according to TNM Stage, Advanced Liver Cancer Prognostic System (ALCPS) and Child-Pugh Score (1989). The patients enrolled were followed up until the date of death or when censored at the latest date. Overall survival and 3-month mortality were the end points used in this analysis. Survival analysis,Cox regression, relative operating characteristic (ROC), and logistic regression were utilized to access the prognostic value of the score systems. RESULTS: ALCPS presented well discriminary ability for prognosis in KaplanMeier analysis. And logistic regression and ROC analysis confirmed that ALCPS was the best prognostic system for 3-month Survival. Its area under curve was as high as 0.85. The cut-off point for ALCPS was 14 with sensitivity of 81.82 % (72/88) and specificity of 79.01 % (64/81, P=0. 000 1). CONCLUSION: ALCPS is good score system in prediction of 3-month mortality among the current systems analyzed, and ALCPS might be proper prognostci criteria for advanced HCC.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第7期485-488,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 广东省科技计划(2009B060700024 2011B031800076)
关键词 肝癌 晚期 生存 评分系统 hepatocellular carcinoma mortality survival clinical trial
  • 相关文献

参考文献15

  • 1戴映,潘跃银,陈振东.中晚期肝细胞肝癌的靶向治疗动态[J].中华肿瘤防治杂志,2010,17(15):1231-1234. 被引量:7
  • 2赵宏,蔡建强.原发性肝癌非手术治疗的现状与展望[J].中华肝胆外科杂志,2011,17(7):527-530. 被引量:23
  • 3Yau T,Yao TJ,Chan P,et al. A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication [or patient selection in sys- temic therapy trials[J]. Cancer,2008,113(10) :2742-2751. 被引量:1
  • 4曾昭冲.肝细胞肝癌放射治疗现状与展望[J].中华肿瘤防治杂志,2009,16(13):961-965. 被引量:22
  • 5Llovet JM, Ricci S, MazzaIerro V, el al. SoraIenib in advanced hepatoeellular earcinoma[J]. N Engl J Med, 2008,359 (4) : 378- 390. 被引量:1
  • 6Cheng AL,Kang YK,Chen Z,et al. Efficacy and safety of sorJ afenib in patients in the Asia-Pacific region with advanced hepaJ tocellular carcinoma:a phase HI randomised, double-blind, plaeeJ bo-controlled trial[J]. Lancet Oncol, 2009,10 (1) : 25-34. |. 被引量:1
  • 7Sarma S, Sharma B, Chaw|a YK, et al. Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinoma[J].Trop Gastroenterol, 2010,31(4) : 271-278. 被引量:1
  • 8H siao SY, Chen SF, Chang CC, et al. Central nervous system involve- ment in hepatocellular carcinoma:clinical characteristics and compari- son of intracranial and spinal metastatic groups[J]. J Clin Neurosci, 2011,18(3) : 364-368. 被引量:1
  • 9Marrero JA,Kudo M,Bronowicki JP. The challenge of prognosis and staging for hepatocelluIar carcinoma [J]. Oncologist, 2010, 15 Suppl 4:23-33. 被引量:1
  • 10Camma C,Cabibbo G. Prognostic scores for hepatocellular carci- noma:none is the winner[J]. Liver Int,2009,29(4) :478 4,80. 被引量:1

二级参考文献66

共引文献63

同被引文献109

  • 1刘金明,张克勤,李涛.肝癌多次TACE术后的肝硬化分级及预后因素分析[J].实用癌症杂志,2014,29(1):68-71. 被引量:24
  • 2丁永珍,周玲坤,冯伟平,刘慧.肝癌晚期患者32例的临终关怀与护理经验探讨[J].吉林医学,2013,34(13):2593-2594. 被引量:12
  • 3陈斌,罗荣城,黄宇贤,丁彦青.EGFR、HER-2/neu蛋白在胃癌中的表达及其预后价值研究[J].解放军医学杂志,2007,32(8):856-859. 被引量:11
  • 4Aoki T, Kokudo N, Matsuyama Y, et al. Prognostic Impact of spontaneous tumor rupture in patients with hepatocellular carci- noma:an analysis of 1160 Cases from a nationwide survey[J]. Ann Surg,2014,259(3) :532-542. 被引量:1
  • 5Miyoshi A, Kitahara K, Kohya N, et al. Outcomes of patients with spontaneous rupture of hepatocellular carcinoma[J]. Hepa- togastroenterology, 2 011,5 8 ( 10 5 ) : 9 9-10 2. 被引量:1
  • 6Zhang XF, Wei T, Liu XM, et al. Spontaneous tumor rupture and surgical prognosis of patients with hepatocellular carcinoma [J]. Stand J Gastroenterol,2012,47(8-9) :968-974. 被引量:1
  • 7Yang T, Sun YF, Zhang J, et al. Partial hepatectomy for rup- tured hepatocellular carcinoma[J]. Br J Surg, 2013, 100 (8) : 1071-1079. 被引量:1
  • 8Wszolek J,Burenok A. One-stage emergency right hemihepatec- tomy due to spontaneous rupture of hepatocellular carcinoma: case report[J]. Pol Przegl Chit,2011,83(6): 339-342. 被引量:1
  • 9Chik BH,Liu CL,Fan ST,et al. Tumor size and operative risks of extended right-sided hepatic resection for hepatocellular carci- noma:implication for preoperative portal vein embolization[J]. Arch Surg,2007,142(1) :63-69. 被引量:1
  • 10Choi KK, Kim SH,Choi SB, et al. Portal venous invasion the single most independent risk factor for immediate postoperative recurrenceof hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2011,26 (11) .. 1646-1651. 被引量:1

引证文献9

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部